@fruity,
Not sure if you are trolling (if you are you can join CEO - the only poster from this stock on my ignore). But I'll give you the benefit of the doubt this time and respond.
Objectively, ID has failed his own deadline in relation to financing twice (once being the early 2018, second being the mid 2018) - there is no other way of interpreting this. Its in black and white and its failed to eventuate.
WSGP gas agreement was ammemded to a less favourable position. Its now only 16TJ, down from 50TJ.
Yes the share price has increased from 20c over the past 3 years, but so has almost every other oil and gas asset - ID did not cause this, any CEO could have delivered this return we've seen.
I have nothing against ID, and if I didn't hold as much SXY as I do then I wouldn't care about what has failed to be accomplished to date.
We can discuss this professionally, but if you think ID has delivered something please enlighten me.
If not, all I ask is that you think before you vote at the upcoming AGM.
SXY has been poised to deliver returns for far too long now, talk is becoming cheap. Time for ID to walk the walk, one way or out the door.
- Forums
- ASX - By Stock
- Ann: Senex completes asset portfolio review
@fruity, Not sure if you are trolling (if you are you can join...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SXY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online